Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention?
Concerns over the influence of pharmaceutical gifts on physicians have surged in recent years. This has prompted wide ranging legislative proposals in numerous states and in the federal government as well as stepped up efforts at self-regulation by the pharmaceutical industry and the medical profession. Policymakers face the decision of whether to defer to self-regulation or support government intervention. This commentary describes efforts at self-regulation by the pharmaceutical industry and the medical profession. The author examines and critiques the wide ranging legislative strategies pursued to limit the influence of pharmaceutical gifts on physicians and concludes with suggestions for policymakers and the profession to limit influence and preserve public trust.
Grande
David
D
Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. dgrande@wharton.upenn.edu
D001291:Attitude of Health Personnel; D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence*; D004992:Ethics, Medical; D037921:Gift Giving / Q000941:ethics; D033161:Government Regulation; D006801:Humans; D007400:Interprofessional Relations / Q000941:ethics; D010820:Physicians / Q000941:ethics / Q000331:legislation & jurisprudence*; D012927:Social Control, Informal